Outcome of Liver Cancer Patients With SARS-CoV-2 Infection Outcome of Liver Cancer Patients With SARS-CoV-2 Infection
This study characterizes the 30-day mortality risk of SARS-CoV-2 infected patients with hepatocellular carcinoma.Liver International
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Transplant | SARS | Study | Transplant Surgery | Transplants | Urology & Nephrology